Your session is about to expire
← Back to Search
Regional Anesthetic
SPG Block for Subarachnoid Hemorrhage
Phase 1
Waitlist Available
Led By Narayan Kissoon, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights
Study Summary
This trial is testing a new implant to relieve headache pain for people who have had an aneurysm bleed.
Eligible Conditions
- Headache
- Subarachnoid Hemorrhage
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 day
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Reduction in patient reported pain using a standard numeric rating scale (NRS)
Trial Design
1Treatment groups
Experimental Treatment
Group I: Open Label ArmExperimental Treatment1 Intervention
Patients will receive a 5mL injection comprised of 4.5mL 1% bupivacaine and 0.5mL of dexamethasone (10mg/mL) directed towards the sphenopalatine ganglion. This will be performed on both sides. Patients will be asked to rate their pain pre- and 30 minutes post-procedure on a scale of 0-10. Patients will also be asked to rate their nausea and photophobia on a similar scale. Patients will be reevaluated at 24 hours and 48 hours post procedure.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Regional anesthetic SPG block-bilateral
2020
Completed Phase 1
~10
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,208 Previous Clinical Trials
3,767,048 Total Patients Enrolled
17 Trials studying Headache
1,070 Patients Enrolled for Headache
Narayan Kissoon, MDPrincipal InvestigatorMayo Clinic
1 Previous Clinical Trials
100 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have not experienced a brain bleed from a non-aneurysmal injury.You have experienced a rupture in an aneurysm located in the back of your brain.You have pain that is rated 5 or higher out of 10 in severity.You have signs of blood vessel narrowing in your brain.You have had a type of stroke called aneurysmal subarachnoid hemorrhage in a specific part of your brain.You must have had a procedure to fix a bulging blood vessel using a method called endovascular coiling.
Research Study Groups:
This trial has the following groups:- Group 1: Open Label Arm
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger